← Back to SNOA

Sonoma Pharmaceuticals, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Dec 2025Filed 10/02/2026Sep 2025Filed 10/02/2026Jun 2025Filed 06/08/2026Dec 2024Filed 10/02/2026Sep 2024Filed 10/02/2026Jun 2024Filed 10/02/2026Dec 2023Filed 05/02/2025
$6.4$4.3$5.6$4$3.6$3.6$3.4$3.1
−$0.3−$0.8−$0.5−$1.2−$0.9−$0.6−$1.1−$0.9
−$0.09−$0.48−$0.32−$0.76−$0.63−$0.59−$1.34−$1.59
3.81.71.61.61.51

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.